BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7893155)

  • 1. Reaction of carbon monoxide and molecular oxygen with P450terp (CYP108) and P450BM-3 (CYP102).
    Sevrioukova IF; Peterson JA
    Arch Biochem Biophys; 1995 Mar; 317(2):397-404. PubMed ID: 7893155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site analysis of P450 enzymes: comparative magnetic circular dichroism spectroscopy.
    Andersson LA; Johnson AK; Peterson JA
    Arch Biochem Biophys; 1997 Sep; 345(1):79-87. PubMed ID: 9281314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site topologies of bacterial cytochromes P450101 (P450cam), P450108 (P450terp), and P450102 (P450BM-3). In situ rearrangement of their phenyl-iron complexes.
    Tuck SF; Peterson JA; Ortiz de Montellano PR
    J Biol Chem; 1992 Mar; 267(8):5614-20. PubMed ID: 1544935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of active site topology to substrate specificity for cytochrome P450terp (CYP108).
    Fruetel JA; Mackman RL; Peterson JA; Ortiz de Montellano PR
    J Biol Chem; 1994 Nov; 269(46):28815-21. PubMed ID: 7961838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily.
    Boddupalli SS; Hasemann CA; Ravichandran KG; Lu JY; Goldsmith EJ; Deisenhofer J; Peterson JA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5567-71. PubMed ID: 1608967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P450BM-3: reduction by NADPH and sodium dithionite.
    Peterson JA; Boddupalli SS
    Arch Biochem Biophys; 1992 May; 294(2):654-61. PubMed ID: 1567220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of the sesquiterpene (+)-valencene by cytochrome P450cam and P450BM-3.
    Sowden RJ; Yasmin S; Rees NH; Bell SG; Wong LL
    Org Biomol Chem; 2005 Jan; 3(1):57-64. PubMed ID: 15602599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA; Roman LJ; Miller RT; Masters BS
    Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
    Murataliev MB; Feyereisen R
    Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
    Sevrioukova I; Truan G; Peterson JA
    Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
    Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
    Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
    Yeom H; Sligar SG
    Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dithionite-supported hydroxylation of palmitic acid by cytochrome P450BM-3.
    Fang X; Halpert JR
    Drug Metab Dispos; 1996 Nov; 24(11):1282-5. PubMed ID: 8937865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon monoxide binding to cytochrome P450BM-3: evidence for a substrate-dependent conformational change.
    McLean MA; Yeom H; Sligar SG
    Biochimie; 1996; 78(8-9):700-5. PubMed ID: 9010598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-site analysis of ferric P450 enzymes: hydrogen-bonding effects on the circular dichroism spectra.
    Andersson LA; Peterson JA
    Biochem Biophys Res Commun; 1995 Jun; 211(2):389-95. PubMed ID: 7794248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational dynamics in cytochrome P450-substrate interactions.
    Li H; Poulos TL
    Biochimie; 1996; 78(8-9):695-9. PubMed ID: 9010597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.